✦ LIBER ✦

Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer

✍ Scribed by Bendell, Johanna C.; Lenz, Heinz-Josef; Ryan, Theresa; El-Rayes, Bassel F.; Marshall, John L.; Modiano, Manuel R.; Hart, Lowell L.; Kingsley, Clint D.; George, Thomas J.; Nakashima, Daisuke; Berlin, Jordan D.

Book ID: 125358937
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 223 KB
Volume: 32
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-014-0088-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, Pharmacokinetics a

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of Ganitumab, an Investigational Fully Human Monoclonal Antibody to Insulin-like Growth Factor Type 1 Receptor, Combined with Gemcitabine as First-line Therapy in Patients with Metastatic Pancreatic Cancer: A Phase 1b Study

✍ Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 157 KB